BioInvent International AB (publ) (STO:BINV)
2.090
-0.080 (-3.69%)
Nov 20, 2026, 5:29 PM CET
STO:BINV Market Cap
STO:BINV has a market cap or net worth of 137.53 million as of November 20, 2026. It is the 39,205th most valuable company in the world and the 559th biggest in Sweden. Its market cap has decreased by 93.31% in one year.
Market Cap
137.53M
Enterprise Value
-67.70M
Revenue
39.98M
Global Rank
Country Rank
#559 Sweden
PE Ratio
n/a
ChartMarket Cap Chart
Since June 14, 2001, STO:BINV's market cap has decreased from 1.20B to 137.53M, a decrease of -88.58%. That is a compound annual growth rate of -8.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 137.53M | -92.89% |
| Dec 30, 2025 | 1.93B | -23.64% |
| Dec 30, 2024 | 2.53B | 103.06% |
| Dec 29, 2023 | 1.25B | -40.08% |
| Dec 30, 2022 | 2.08B | -22.92% |
| Dec 30, 2021 | 2.70B | 54.06% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Xbrane Biopharma AB | 219.45M |
| Mendus AB | 212.94M |
| Initiator Pharma | 175.24M |
| Elicera Therapeutics AB | 162.84M |
| Simris Group AB (PUBL) | 149.13M |
| Diamyd Medical AB | 145.22M |
| Abera Bioscience AB | 140.62M |
| Xintela AB | 120.58M |